While the drugmaker reaffirmed its 2025 revenue guidance of $61bn to $64bn, it raised its full-year 2025 profit outlook. Pfizer now expects to earn $2.90 to $3.10 per share, compared with its previous ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive surprises than negative ones.